Proactively Bridging the Early Stage Funding Gap

An interview with Sinclair Dunlop, Managing Partner at Epidarex Capital

Sinclair Dunlop, Managing Partner at transatlantic venture capital firm Epidarex Capital, talks to Biotechand Money about the life science sub-sectors with unrealised potential, provides his top tips for early stage life science companies looking for investment, and outlines the firm’s ambitions to scale up in order to provide further support to young companies in under-ventured markets.

Please click here to download the full interview published by Biotech and Money.